Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Bio-Techne
ISIN US09073M1045
|WKN A12ENG
Market cap (in EUR)
8,794 m
Country
United States
Sector
Healthcare
Dividend yield
0.49%
Overview
Description
Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Its products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Spatial Biology segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.
Healthcare Healthcare Services Miscellaneous Healthcare United States
Financials
Key metrics
| Market capitalisation, EUR | 8,794 m |
| EPS, EUR | 0.44 |
| P/B ratio | 5.2 |
| P/E ratio | 134.3 |
| Dividend yield | 0.49% |
Income statement (2025)
| Revenue, EUR | 1,122 m |
| Net income, EUR | 67 m |
| Profit margin | 6.02% |
What ETF is Bio-Techne in?
There are 15 ETFs which contain Bio-Techne. All of these ETFs are listed in the table below. The ETF with the largest weighting of Bio-Techne is the Amundi MSCI Disruptive Technology UCITS ETF Acc.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.